{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:12:58Z","timestamp":1793121178740,"version":"4.5.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"17","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["708002"],"award-info":[{"award-number":["708002"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023324","name":"Canadian Association of Medical Oncologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-153234"],"award-info":[{"award-number":["FRN-153234"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-168933"],"award-info":[{"award-number":["FRN-168933"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-191847"],"award-info":[{"award-number":["FRN-191847"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-198247"],"award-info":[{"award-number":["FRN-198247"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-158225"],"award-info":[{"award-number":["FRN-158225"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["IA 031"],"award-info":[{"award-number":["IA 031"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["P.OCT.051"],"award-info":[{"award-number":["P.OCT.051"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["P.AO.075"],"award-info":[{"award-number":["P.AO.075"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The management of metastatic breast cancer (mBC) relies on tissue-based immunohistochemical subtypes. However, biopsies are invasive and may not capture metastatic heterogeneity, and subtypes can change over time under treatment pressure. In this study, we developed cell-free DNA (cfDNA) methylation signatures for minimally invasive breast cancer detection, distinction, and estrogen receptor (ER) status classification. Peripheral blood plasma methylomes were analyzed from 79 patients with mBC spanning ER+\/human epidermal growth factor receptor 2 (HER2)\u2212 (n = 45), HER2+ (n = 13), and triple-negative breast cancer (n = 21). To derive tissue-informed breast cancer and ER-specific features, public 450K methylation array data (n = 9,730) were leveraged, and features were selected using generalized linear models via elastic net regularization with cross-validation. The tissue-informed features were translated to cell-free methylated DNA immunoprecipitation and sequencing (cfMeDIP-seq), and the final signatures were validated across a compendium of cfMeDIP-seq profiles (n = 713) spanning more than 10 cancer types. Across training, validation, and external test cohorts, the signatures demonstrated high accuracy for breast cancer detection versus controls, distinction from multiple other malignancies, and ER status classification. Performance generalized across independent cfMeDIP-seq cohorts and reflected tumor fraction. The sensitivity was reduced in samples with low tumor fractions and bone-only disease while remaining informative for typical tumor fractions observed in the metastatic setting. Promoter-proximal signature regions provided biological insight into tumor phenotypes. This tissue-anchored, platform-translatable framework demonstrates the feasibility of accurate, reproducible cfDNA methylation-based molecular classification in mBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Tissue-anchored cell-free DNA methylation signatures enable minimally invasive detection, cancer-type distinction, and estrogen receptor classification in metastatic breast cancer, offering an interpretable, cross-platform framework to complement tissue biopsies for guiding subtype-directed therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-26-0076","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:59:04Z","timestamp":1781103544000},"page":"4365-4380","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-8323","authenticated-orcid":false,"given":"Sasha C.","family":"Main","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 2 Department of Medical Biophysics, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-7287","authenticated-orcid":false,"given":"Mitchell J.","family":"Elliott","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 4 Institute of Medical Science, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2985-4794","authenticated-orcid":false,"given":"Althaf","family":"Singhawansa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-0961","authenticated-orcid":false,"given":"Jinfeng","family":"Zou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1272","authenticated-orcid":false,"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9174-1099","authenticated-orcid":false,"given":"Nicholas","family":"Cheng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043q8yx54","id-type":"ROR","asserted-by":"publisher"}],"name":"Ontario Institute for Cancer Research 5 , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-1091","authenticated-orcid":false,"given":"Celeste","family":"Yu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-8633","authenticated-orcid":false,"given":"John F.","family":"Hilton","sequence":"additional","affiliation":[{"name":"6Division of Medical Oncology, Ottawa Hospital Cancer Centre, Ottawa, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-6393","authenticated-orcid":false,"given":"Philip","family":"Awadalla","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Oxford 7 Department of Population Health, Big Data Institute, , Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-3363","authenticated-orcid":false,"given":"Housheng H.","family":"He","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 2 Department of Medical Biophysics, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-2999","authenticated-orcid":false,"given":"Philippe L.","family":"Bedard","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0929-9478","authenticated-orcid":false,"given":"Mathieu","family":"Lupien","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 2 Department of Medical Biophysics, , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/043q8yx54","id-type":"ROR","asserted-by":"publisher"}],"name":"Ontario Institute for Cancer Research 5 , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-4908","authenticated-orcid":false,"given":"Scott V.","family":"Bratman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 1 , University Health Network, Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 2 Department of Medical Biophysics, , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 8 Department of Radiation Oncology, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1080-0998","authenticated-orcid":false,"given":"David W.","family":"Cescon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 3 Division of Medical Oncology and Hematology, Department of Medicine, , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto 4 Institute of Medical Science, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"2026090203143302900_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"2026090203143302900_bib2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026090203143302900_bib3","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026090203143302900_bib4","doi-asserted-by":"crossref","first-page":"e390922","DOI":"10.1200\/EDBK_390922","article-title":"Managing a long and winding road: estrogen receptor-positive breast cancer","volume":"43","author":"Gnant","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026090203143302900_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","article-title":"A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases","volume":"50","author":"Aurilio","year":"2014","journal-title":"Eur J Cancer"},{"key":"2026090203143302900_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat Cancer"},{"key":"2026090203143302900_bib7","doi-asserted-by":"crossref","first-page":"eaaw3616","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"2026090203143302900_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","article-title":"Sensitive tumour detection and classification using plasma cell-free DNA methylomes","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"2026090203143302900_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/15592294.2021.1896984","article-title":"Cell-free DNA methylome profiling by MBD-seq with ultra-low input","volume":"17","author":"Huang","year":"2022","journal-title":"Epigenetics"},{"key":"2026090203143302900_bib10","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/s41591-023-02605-z","article-title":"Liquid biopsy epigenomic profiling for cancer subtyping","volume":"29","author":"Baca","year":"2023","journal-title":"Nat Med"},{"key":"2026090203143302900_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s43018-022-00415-9","article-title":"cfDNA methylome profiling for detection and subtyping of small cell lung cancers","volume":"3","author":"Chemi","year":"2022","journal-title":"Nat Cancer"},{"key":"2026090203143302900_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/2159-8290.CD-23-1060","article-title":"Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors","volume":"14","author":"Stutheit-Zhao","year":"2024","journal-title":"Cancer Discov"},{"key":"2026090203143302900_bib13","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1158\/1078-0432.CCR-21-0110","article-title":"Tumor-naive multimodal profiling of circulating tumor DNA in head and neck squamous cell carcinoma","volume":"27","author":"Burgener","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2026090203143302900_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","article-title":"Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes","volume":"26","author":"Nassiri","year":"2020","journal-title":"Nat Med"},{"key":"2026090203143302900_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41591-020-0933-1","article-title":"Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes","volume":"26","author":"Nuzzo","year":"2020","journal-title":"Nat Med"},{"key":"2026090203143302900_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"key":"2026090203143302900_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1186\/s12967-024-05734-2","article-title":"Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1\/2 mutation","volume":"22","author":"Grisolia","year":"2024","journal-title":"J Transl Med"},{"key":"2026090203143302900_bib18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41467-023-36801-9","article-title":"Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer","volume":"14","author":"Prat","year":"2023","journal-title":"Nat Commun"},{"key":"2026090203143302900_bib19","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/s41467-022-35076-w","article-title":"A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA","volume":"13","author":"Doebley","year":"2022","journal-title":"Nat Commun"},{"key":"2026090203143302900_bib20","doi-asserted-by":"crossref","first-page":"bbad015","DOI":"10.1093\/bib\/bbad015","article-title":"MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples","volume":"24","author":"Romagnoli","year":"2023","journal-title":"Brief Bioinform"},{"key":"2026090203143302900_bib21","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1002\/ctm2.1014","article-title":"Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer","volume":"12","author":"Gao","year":"2022","journal-title":"Clin Transl Med"},{"key":"2026090203143302900_bib22","doi-asserted-by":"crossref","first-page":"e19888","DOI":"10.7717\/peerj.19888","article-title":"Genome-wide discovery of circulating cell-free DNA methylation signatures for the differential diagnosis of triple-negative breast cancer","volume":"13","author":"Gao","year":"2025","journal-title":"PeerJ"},{"key":"2026090203143302900_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tig.2023.01.004","article-title":"Bridging biological cfDNA features and machine learning approaches","volume":"39","author":"Moser","year":"2023","journal-title":"Trends Genet"},{"key":"2026090203143302900_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s43018-026-01116-3","article-title":"A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection","volume":"7","author":"Zeng","year":"2026","journal-title":"Nat Cancer"},{"key":"2026090203143302900_bib25","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat Commun"},{"key":"2026090203143302900_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13059-021-02275-5","article-title":"Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders","volume":"22","author":"Nabais","year":"2021","journal-title":"Genome Biol"},{"key":"2026090203143302900_bib27","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.1073\/pnas.1816847116","article-title":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk","volume":"116","author":"Zannas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090203143302900_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"2026090203143302900_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat Genet"},{"key":"2026090203143302900_bib30","doi-asserted-by":"crossref","first-page":"105487","DOI":"10.1016\/j.isci.2022.105487","article-title":"Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction","volume":"25","author":"Ul Haq","year":"2022","journal-title":"iScience"},{"key":"2026090203143302900_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/2159-8290.CD-23-0456","article-title":"Early cancer detection in Li-Fraumeni syndrome with cell-free DNA","volume":"14","author":"Wong","year":"2024","journal-title":"Cancer Discov"},{"key":"2026090203143302900_bib32","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1038\/s41467-022-34012-2","article-title":"The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"2026090203143302900_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/2767-9764.CRC-22-0456","article-title":"Integrated, longitudinal analysis of cell-free DNA in uveal melanoma","volume":"3","author":"Wong","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2026090203143302900_bib34","doi-asserted-by":"crossref","first-page":"100294","DOI":"10.1016\/j.crmeth.2022.100294","article-title":"Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls","volume":"2","author":"Wilson","year":"2022","journal-title":"Cell Rep Methods"},{"key":"2026090203143302900_bib35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s43018-020-0096-5","article-title":"Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab","volume":"1","author":"Bratman","year":"2020","journal-title":"Nat Cancer"},{"key":"2026090203143302900_bib36","doi-asserted-by":"crossref","first-page":"e103896","DOI":"10.1371\/journal.pone.0103896","article-title":"Remodeling of the methylation landscape in breast cancer metastasis","volume":"9","author":"Reyngold","year":"2014","journal-title":"PLoS One"},{"key":"2026090203143302900_bib37","doi-asserted-by":"crossref","first-page":"e22618","DOI":"10.1096\/fj.202200751RR","article-title":"RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression","volume":"36","author":"Jiang","year":"2022","journal-title":"FASEB J"},{"key":"2026090203143302900_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41419-021-03661-4","article-title":"MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026090203143302900_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1741-7015-9-133","article-title":"Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer","volume":"9","author":"Warren","year":"2011","journal-title":"BMC Med"},{"key":"2026090203143302900_bib40","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1200\/JCO.2007.14.1697","article-title":"Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients","volume":"26","author":"Harbeck","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026090203143302900_bib41","doi-asserted-by":"crossref","first-page":"e50233","DOI":"10.1371\/journal.pone.0050233","article-title":"A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the Infinium HumanMethylation450 BeadChip(\u00ae) for methylome profiling","volume":"7","author":"Clark","year":"2012","journal-title":"PLoS One"},{"key":"2026090203143302900_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.annonc.2019.11.014","article-title":"Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer","volume":"31","author":"Moss","year":"2020","journal-title":"Ann Oncol"},{"key":"2026090203143302900_bib43","doi-asserted-by":"crossref","first-page":"1758835919833519","DOI":"10.1177\/1758835919833519","article-title":"HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance","volume":"11","author":"Pernas","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"2026090203143302900_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.breast.2019.12.010","article-title":"Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer","volume":"49","author":"Guan","year":"2020","journal-title":"Breast"},{"key":"2026090203143302900_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"key":"2026090203143302900_bib46","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1101\/gr.266551.120","article-title":"Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA","volume":"31","author":"Vaisvila","year":"2021","journal-title":"Genome Res"},{"key":"2026090203143302900_bib47","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41587-022-01652-0","article-title":"Simultaneous sequencing of genetic and epigenetic bases in DNA","volume":"41","author":"F\u00fcllgrabe","year":"2023","journal-title":"Nat Biotechnol"},{"key":"2026090203143302900_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10549-025-07740-4","article-title":"Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes study","volume":"212","author":"Bader","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"2026090203143302900_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.annonc.2022.09.163","article-title":"Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study","volume":"34","author":"Reichert","year":"2023","journal-title":"Ann Oncol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-26-0076\/3802895\/can-26-0076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-26-0076\/3809281\/can-26-0076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/17\/4365\/3823126\/can-26-0076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/17\/4365\/3823126\/can-26-0076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:14:51Z","timestamp":1788333291000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/17\/4365\/787506\/Circulating-Cell-Free-DNA-Methylation-Profiling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":49,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,6,10]]},"published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-26-0076","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.33414543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414540","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414516","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33414519","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8688012","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}